Related Experiment Video

Updated: May 23, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

14.6K

Correction: Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington's Disease: Data from

Erin Furr Stimming1, Daniel O Claassen2, Ginny P Sen3

  • 1The University of Texas Health Science Center at Houston, Houston, TX, USA.

Neurology and Therapy
|April 4, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.1K
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.4K

Related Experiment Videos

Last Updated: May 23, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

14.6K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.1K
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.4K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

178
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
178
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

415
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
415

Articles linked to this work by shared authors, journal, and citation graph.

Delusional infestation in Parkinson disease: a case report of medication-induced psychosis.

Neurocase·2026

Cutaneous alpha-synuclein deposition informs autonomic function in individuals with early-stage multiple system atrophy.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2026

Revisiting the Link Between Huntington's Disease and Cancer: Evidence from the Enroll-HD dataset.

Neuroepidemiology·2026

Practical recommendations for the treatment of chorea associated with Huntington's disease: An expert consensus.

Journal of Huntington's disease·2026

Choroid plexus calcification detection using quantitative susceptibility mapping MRI.

medRxiv : the preprint server for health sciences·2026

Sleep in Huntington's disease gene expansion carriers: A systematic review.

Sleep medicine·2026

Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan.

Neurology and therapy·2026

Smartphone-Based Multimodal Digital Biomarker Integration for Parkinson's Disease Screening and Diagnostic Support.

Neurology and therapy·2026

Narrative Review: Efficacy, Safety, and Tolerability of Newer Third-Generation Antiseizure Medications for Focal Epilepsy: A New Benchmark in Treatment Outcomes?

Neurology and therapy·2026

Artificial Intelligence in Neuromuscular Diseases: Opportunities for a Data-Scarce Field.

Neurology and therapy·2026

The Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Post-Diagnosis: Results from an International Survey.

Neurology and therapy·2026

Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan.

Neurology and therapy·2026

[When growth hormone levels drop - Management with urea of postoperative inappropriate antidiuretic hormone secretion syndrome in a patient who underwent surgery for acromegaly].

Nutricion hospitalaria·2026

Health seeking behaviours of those accessing primary Eye care services in Tamil Nadu, India.

Eye (London, England)·2026

Barriers to medication adherence and health access among young people living with HIV in Kumasi, Ghana.

AIDS care·2026

Postoperative Care After Transurethral Resection (TURP and TURBT): Early Mobilization, Activity Restriction, and Convalescence - A Scoping Review.

Urologia internationalis·2026

Entwicklung einer Definition "Äusserer Anwendungen" - Integrative Review und Delphi-Studie.

Complementary medicine research·2026

Ethyl acetate fraction of Abeliophyllum distichum Nakai alleviates atopic dermatitis-like symptoms in vivo and in vitro model.

Journal of traditional and complementary medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us